These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9505994)

  • 1. The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.
    Snel S; Jansen JA; Mengel HB; Richens A; Larsen S
    J Clin Pharmacol; 1997 Nov; 37(11):1015-20. PubMed ID: 9505994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs.
    So EL; Wolff D; Graves NM; Leppik IE; Cascino GD; Pixton GC; Gustavson LE
    Epilepsy Res; 1995 Nov; 22(3):221-6. PubMed ID: 8991789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures.
    Gustavson LE; Boellner SW; Granneman GR; Qian JX; Guenther HJ; el-Shourbagy T; Sommerville KW
    Neurology; 1997 Apr; 48(4):1032-7. PubMed ID: 9109895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.
    Samara EE; Gustavson LE; El-Shourbagy T; Locke C; Granneman GR; Sommerville KW
    Epilepsia; 1998 Aug; 39(8):868-73. PubMed ID: 9701378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function.
    Lau AH; Gustavson LE; Sperelakis R; Lam NP; El-Shourbagy T; Qian JX; Layden T
    Epilepsia; 1997 Apr; 38(4):445-51. PubMed ID: 9118850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical implications of pharmacology and pharmacokinetics of tiagabine].
    Pita-Calandre E
    Rev Neurol; 1999 Feb 1-15; 28(3):337-9. PubMed ID: 10714305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy in the elderly: the use of tiagabine.
    Pedersen B
    Epilepsia; 2001; 42 Suppl 3():52-4. PubMed ID: 11520325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of pharmacokinetic interaction between tiagabine and erythromycin.
    Thomsen MS; Groes L; Agersø H; Kruse T
    J Clin Pharmacol; 1998 Nov; 38(11):1051-6. PubMed ID: 9824787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin.
    Snel S; Jansen JA; Pedersen PC; Jonkman JH; van Heiningen PN
    Eur J Clin Pharmacol; 1998 Jun; 54(4):355-7. PubMed ID: 9696964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of renal impairment on the pharmacokinetics and tolerability of tiagabine.
    Cato A; Gustavson LE; Qian J; El-Shourbagy T; Kelly EA
    Epilepsia; 1998 Jan; 39(1):43-7. PubMed ID: 9578011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine.
    Shinnar S
    Semin Pediatr Neurol; 1997 Mar; 4(1):24-33. PubMed ID: 9097364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic drug monitoring of tiagabine].
    Bentué-Ferrer D; Tribut O; Verdier MC;
    Therapie; 2010; 65(1):51-5. PubMed ID: 20205996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of a clinically significant pharmacokinetic drug interaction between tiagabine and valproate.
    Gustavson LE; Sommerville KW; Boellner SW; Witt GF; Guenther HJ; Granneman GR
    Am J Ther; 1998 Mar; 5(2):73-9. PubMed ID: 10099041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of tiagabine: summary of 53 trials.
    Leppik IE; Gram L; Deaton R; Sommerville KW
    Epilepsy Res; 1999 Feb; 33(2-3):235-46. PubMed ID: 10094434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of tiagabine in epileptic patients on monotherapy.
    Ingwersen SH; Pedersen PC; Groes L; Nielsen KK; Aarons L
    Eur J Pharm Sci; 2000 Sep; 11(3):247-54. PubMed ID: 11042231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the antiepileptic drug tiagabine.
    Schachter SC
    Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiagabine and non-convulsive status epilepticus.
    Schapel G; Chadwick D
    Seizure; 1996 Jun; 5(2):153-6. PubMed ID: 8795133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses.
    Gustavson LE; Mengel HB
    Epilepsia; 1995 Jun; 36(6):605-11. PubMed ID: 7555975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician.
    Schmidt D; Gram L; Brodie M; Krämer G; Perucca E; Kälviäinen R; Elger CE
    Epilepsy Res; 2000 Oct; 41(3):245-51. PubMed ID: 10962215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.